respirmycin- tulathromycin injection, solution
parnell technologies pty ltd - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - indications beef and non-lactating dairy cattle brd – respirmycin injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni , and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica, pasteurella multocida, histophilus somni , and mycoplasma bovis . ibk – respirmycin injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot – respirmycin injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii . suckling calves, dairy calves, and veal calves brd – respirmycin injectable solution is indicated for the treatment of brd associated with m. haemolytica, p. multocida, h. somni , and m. bovis . swine res
vacasan- tulathromycin injection, solution
huvepharma, inc. - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - indications beef and non-lactating dairy cattle brd – vacasan injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni , and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica, pasteurella multocida, histophilus somni , and mycoplasma bovis . ibk – vacasan injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot – vacasan injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii . suckling calves, dairy calves, and veal calves brd – vacasan injectable solution is indicated for the treatment of brd associated with m. haemolytica, p. multocida, h. somni , and m. bovis . swine vacasan injectable
jurox tulathromycin injection
jurox pty limited - tulathromycin - parenteral liquid/solution/suspension - tulathromycin antibiotic active 100.0 mg/ml - antibiotic & related
randlab tulathromycin injection
randlab australia pty ltd - tulathromycin - parenteral liquid/solution/suspension - tulathromycin antibiotic active 100.0 mg/ml - antibiotic & related
elevet+ tulathromycin injection
avet health limited - tulathromycin - parenteral liquid/solution/suspension - tulathromycin antibiotic active 100.0 mg/ml - antibiotic & related
yp tulathromycin injectable
south yarra pharma pty ltd - tulathromycin - parenteral liquid/solution/suspension - tulathromycin antibiotic active 100.0 mg/ml - antibiotic & related
tulaven- tulathromycin solution
ceva sante animale - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - swine tulaven™ 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae , pasteurella multocida , bordetella bronchiseptica , haemophilus parasuis , and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae , pasteurella multocida , and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd – tulaven™ 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . the use of tulaventm 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug.
respirmycin 25- tulathromycin injection, solution
parnell technologies pty ltd - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - indications swine respirmycin 25 injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae , pasteurella multocida , bordetella bronchiseptica , haemophilus parasuis , and mycoplasma hyopneumoniae ; and for the control of srd associated with actinobacillus pleuropneumoniae , pasteurella multocida , and mycoplasma hyopneumoniae in groups of pigs where srd has been diagnosed. suckling calves, dairy calves, and veal calves brd – respirmycin 25 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . contraindications the use of respirmycin 25 injectable solution is contraindicated in animals previously found to be hypersensitive to the drug.
tulaven- tulathromycin solution
ceva sante animale - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - beef and non-lactating dairy cattle brd – tulaven™ 100 injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis ; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica , pasteurella multocida , histophilus somni , and mycoplasma bovis . ibk – tulaven™ 100 injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis . foot rot – tulaven™ 100 injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii . suckling calves, dairy calves, and veal calves brd – tulaven™ 100 injectable solution is indicated for the treatment of brd associated with m. haemolytica , p. multocida , h. somni , and m. bovis . swine tulaven™ 100 injectable solu
tulieve- tulathromycin injection, solution
norbrook laboratories limited - tulathromycin (unii: q839i13422) (tulathromycin - unii:q839i13422) - brd -tulieve injectable solution is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis; and for the control of respiratory disease in cattle at high risk of developing brd associated with mannheimia haemolytica, pasteurella multocida, histophilus somni, and mycoplasma bovis. ibk -tulieve injectable solution is indicated for the treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis. foot rot -tulieve injectable solution is indicated for the treatment of bovine foot rot (interdigital necrobacillosis) associated with fusobacterium necrophorum and porphyromonas levii. brd -tulieve injectable solution is indicated for the treatment of brd associated with m. haemolytica, p.multocida, h. somni, and m. bovis. tulieve injectable solution is indicated for the treatment of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae,pasteurella mu